title: Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells.
abstract: The development of regenerative therapies for cartilage injury has been greatly aided by recent advances in stem cell biology. Induced pluripotent stem cells (iPSCs) have the potential to provide an abundant cell source for tissue engineering, as well as generating patient-matched in vitro models to study genetic and environmental factors in cartilage repair and osteoarthritis. However, both cell therapy and modeling approaches require a purified and uniformly differentiated cell population to predictably recapitulate the physiological characteristics of cartilage. Here, iPSCs derived from adult mouse fibroblasts were chondrogenically differentiated and purified by type II collagen (Col2)-driven green fluorescent protein (GFP) expression. Col2 and aggrecan gene expression levels were significantly up-regulated in GFP+ cells compared with GFP- cells and decreased with monolayer expansion. An in vitro cartilage defect model was used to demonstrate integrative repair by GFP+ cells seeded in agarose, supporting their potential use in cartilage therapies. In chondrogenic pellet culture, cells synthesized cartilage-specific matrix as indicated by high levels of glycosaminoglycans and type II collagen and low levels of type I and type X collagen. The feasibility of cell expansion after initial differentiation was illustrated by homogenous matrix deposition in pellets from twice-passaged GFP+ cells. Finally, atomic force microscopy analysis showed increased microscale elastic moduli associated with collagen alignment at the periphery of pellets, mimicking zonal variation in native cartilage. This study demonstrates the potential use of iPSCs for cartilage defect repair and for creating tissue models of cartilage that can be matched to specific genetic backgrounds.
authors.affiliation: Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC 27710, USA.
authors.forename: Brian O
authors.initials: BO
authors.lastname: Diekman
authors.forename: Nicolas
authors.initials: N
authors.lastname: Christoforou
authors.forename: Vincent P
authors.initials: VP
authors.lastname: Willard
authors.forename: Haosi
authors.initials: H
authors.lastname: Sun
authors.forename: Johannah
authors.initials: J
authors.lastname: Sanchez-Adams
authors.forename: Kam W
authors.initials: KW
authors.lastname: Leong
authors.forename: Farshid
authors.initials: F
authors.lastname: Guilak
mesh_terms: D000818:Animals; D002356:Cartilage / Q000502:physiology*; D002454:Cell Differentiation / Q000235:genetics; D002469:Cell Separation; D065150:Cellular Reprogramming / Q000235:genetics; D020219:Chondrogenesis / Q000235:genetics; D024043:Collagen Type II / Q000378:metabolism; D055119:Elastic Modulus; D005434:Flow Cytometry; D005786:Gene Expression Regulation; D006025:Glycosaminoglycans / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000378:metabolism; D057026:Induced Pluripotent Stem Cells / Q000166:cytology* / Q000378:metabolism*; D051379:Mice; D018625:Microscopy, Atomic Force; D009928:Organ Specificity; D012685:Sepharose; D023822:Tissue Engineering / Q000379:methods*; D014945:Wound Healing
chemical_list: D024043:Collagen Type II; D006025:Glycosaminoglycans; D049452:Green Fluorescent Proteins; D012685:Sepharose